Principal Investigator
Professor of Translational Nephrology
Aging is associated with profound changes in cellular metabolism and the decline in metabolic fitness results in aging-associated diseases. We study metabolic interventions as strategies to prevent organ failure with a specific focus on kidney diseases.
The kidneys are central targets of aging-associated diseases.
Integrity of cellular metabolism in the kidney is a pre-requisite to organ integrity and is affected by aging. Interestingly, interventions that modulate cellular metabolism – e.g., activation of hypoxia signaling or dietary restriction – have shown an amazing potential in protection against kidney failure.
I believe that the extension of human well-being and maintenance of health is a key purpose of research in the life sciences. Closing the gap between basic science and novel strategies in everyday patient care is a major challenge, but also a lot of fun to work on.
Linking RNA biology with the power of model organisms such as C. elegans bears a huge potential to reveal novel approaches for fighting kidney diseases as well as consecutive morbidity and mortality. Unraveling this potential and translating it to clinical use is the lab's declared aim.
C. elegans is one of the key model organisms to study molecular mechanisms regulating longevity and stress resistance. Consequently, a large number of the signal transduction pathways involved in these phenotypes has been identified using the nematode. Work from Dr. Müller and his team was among the first evidence showing that hypoxia-inducible factor signaling is one of these pathways linking stress resistance, longevity, and tumorigenesis even closer to each other. As to non-coding RNAs in the kidney, Prof. Dr. Müller contributed to the very first microRNA expression profiles from different cell types in the kidney. Furthermore, his group published work showing the importance of this RNA species to kidney development and function.
Principal Investigator
Professor of Translational Nephrology